Latest Articles
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 - Fierce Biotech
Endometrial cancer data on Genmab’s Elahere rival beat forecast, fueling push into phase 3 Fierce Biotech
Published: May 23, 2025, 1:22 p.m.
Endometrial Ablation Market projected to reach USD 2,052.22 Million by 2034, growing at a CAGR of 5.1% - openPR.com
Endometrial Ablation Market projected to reach USD 2,052.22 Million by 2034, growing at a CAGR of 5.1% openPR.com
Published: May 23, 2025, 12:38 p.m.
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment - TipRanks
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment TipRanks
Published: May 23, 2025, 10:59 a.m.
Breakthrough Cancer Data: Genmab Reveals First Rina-S Results for Deadly Endometrial Cancer at ASCO 2025 - Stock Titan
Breakthrough Cancer Data: Genmab Reveals First Rina-S Results for Deadly Endometrial Cancer at ASCO 2025 Stock Titan
Published: May 22, 2025, 9:05 p.m.
Navigating complexities of polymorphic microbiomes in endometrial cancer - Nature
Navigating complexities of polymorphic microbiomes in endometrial cancer Nature
Published: May 22, 2025, 6:42 p.m.
Endometrial Hydrothermal System Market Size, Sales, Average Price and Trends Analysis, till 2032 - openPR.com
Endometrial Hydrothermal System Market Size, Sales, Average Price and Trends Analysis, till 2032 openPR.com
Published: May 22, 2025, 11:33 a.m.
Endometrial Cryoablation System Market Size, Sales, Average Price and Trends Analysis, till 2032 - openPR.com
Endometrial Cryoablation System Market Size, Sales, Average Price and Trends Analysis, till 2032 openPR.com
Published: May 22, 2025, 11:17 a.m.
ASCO 2025: A Preview of Advancements in Endometrial Cancer - Medscape
ASCO 2025: A Preview of Advancements in Endometrial Cancer Medscape
Published: May 21, 2025, 5:15 p.m.
ASCO 2025: A Preview of Advancements in Endometrial and Related Cancers - Medscape
ASCO 2025: A Preview of Advancements in Endometrial and Related Cancers Medscape
Published: May 21, 2025, 5:15 p.m.
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer - Medical Dialogues
PORTEC-4a Study Supports Personalized Radiotherapy in Early Endometrial Cancer Medical Dialogues
Published: May 21, 2025, 3 p.m.
Link copied to clipboard!